Hylton NM - Search Results

1

Impact of Alternate b-Value Combinations and Metrics on the Predictive Performance and Repeatability of Diffusion-Weighted MRI in Breast Cancer Treatment: Results from the ECOG-ACRIN A6698 Trial.

Partridge SC, Steingrimsson J, Newitt DC, Gibbs JE, Marques HS, Bolan PJ, Boss MA, Chenevert TL, Rosen MA, Hylton NM. Partridge SC, et al. Among authors: hylton nm. Tomography. 2022 Mar 4;8(2):701-717. doi: 10.3390/tomography8020058. Tomography. 2022. PMID: 35314635 Free PMC article.

2

Semi-automated analysis for MRI of breast tumors.

Partridge SC, Heumann EJ, Hylton NM. Partridge SC, et al. Among authors: hylton nm. Stud Health Technol Inform. 1999;62:259-60. Stud Health Technol Inform. 1999. PMID: 10538368

3

MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer.

Esserman L, Kaplan E, Partridge S, Tripathy D, Rugo H, Park J, Hwang S, Kuerer H, Sudilovsky D, Lu Y, Hylton N. Esserman L, et al. Ann Surg Oncol. 2001 Jul;8(6):549-59. doi: 10.1007/s10434-001-0549-8. Ann Surg Oncol. 2001. PMID: 11456056

4

Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI.

Partridge SC, McKinnon GC, Henry RG, Hylton NM. Partridge SC, et al. Among authors: hylton nm. J Magn Reson Imaging. 2001 Oct;14(4):433-8. doi: 10.1002/jmri.1204. J Magn Reson Imaging. 2001. PMID: 11599068

5

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.

Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM. Partridge SC, et al. Among authors: hylton nm. AJR Am J Roentgenol. 2002 Nov;179(5):1193-9. doi: 10.2214/ajr.179.5.1791193. AJR Am J Roentgenol. 2002. PMID: 12388497

6

MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.

Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Tripathy D, Wolverton DS, Rugo HS, Hwang ES, Ewing CA, Hylton NM. Partridge SC, et al. Among authors: hylton nm. AJR Am J Roentgenol. 2005 Jun;184(6):1774-81. doi: 10.2214/ajr.184.6.01841774. AJR Am J Roentgenol. 2005. PMID: 15908529

7

Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study.

Shah N, Gibbs J, Wolverton D, Cerussi A, Hylton N, Tromberg BJ. Shah N, et al. J Biomed Opt. 2005 Sep-Oct;10(5):051503. doi: 10.1117/1.2070147. J Biomed Opt. 2005. PMID: 16292947 Free article.

8

Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ.

Kumar AS, Chen DF, Au A, Chen YY, Leung J, Garwood ER, Gibbs J, Hylton N, Esserman LJ. Kumar AS, et al. Am J Surg. 2006 Oct;192(4):520-4. doi: 10.1016/j.amjsurg.2006.07.003. Am J Surg. 2006. PMID: 16978965 Free PMC article.

9

Characterization of breast lesions using the 3D FIESTA sequence and contrast-enhanced magnetic resonance imaging.

Klifa CS, Shimakawa A, Siraj Z, Gibbs JE, Wilmes LJ, Partridge SC, Proctor E, Hylton NM. Klifa CS, et al. Among authors: hylton nm. J Magn Reson Imaging. 2007 Jan;25(1):82-8. doi: 10.1002/jmri.20775. J Magn Reson Imaging. 2007. PMID: 17173311

10

Quantification of breast tissue index from MR data using fuzzy clustering.

Klifa C, Carballido-Gamio J, Wilmes L, Laprie A, Lobo C, Demicco E, Watkins M, Shepherd J, Gibbs J, Hylton N. Klifa C, et al. Conf Proc IEEE Eng Med Biol Soc. 2004;2004:1667-70. doi: 10.1109/IEMBS.2004.1403503. Conf Proc IEEE Eng Med Biol Soc. 2004. PMID: 17272023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page